Burning Rock Biotech (BNR) Cash from Investing Activities (2019 - 2026)
Burning Rock Biotech (BNR) posted quarterly Cash from Investing Activities of -$53000.0 for Q1 2026, up 74.88% year-over-year from -$30306.2 in Q1 2025, and down 15.22% quarter-over-quarter from -$46000.0 in Q4 2025.
Burning Rock Biotech (BNR) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Burning Rock Biotech's Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$53000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 74.88% year-over-year to -$53000.0; the TTM figure through Mar 2026 stood at -$670000.0 (up 22.63% YoY), while the FY2025 annual figure was -$628000.0, down 3.97% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$53000.0, down from -$46000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $4.6 million in Q2 2022, with the low at -$2.8 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$272000.0 (2023), against an average of -$247117.6.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities jumped 143.87% in 2022, then tumbled 496.77% in 2025.
- Burning Rock Biotech's Cash from Investing Activities stood at -$730000.0 in 2022, then soared by 93.7% to -$46000.0 in 2023, then tumbled by 141.3% to -$111000.0 in 2024, then soared by 58.56% to -$46000.0 in 2025, then slipped by 15.22% to -$53000.0 in 2026.
- Business Quant data shows BNR's Cash from Investing Activities at -$53000.0 in Q1 2026, -$46000.0 in Q4 2025, and -$386000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -25.50 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -366.20 Mn |
| 10 | Burning Rock Biotech | 84.09 Mn | 14.24 Mn | 11.31 Mn | -53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53,000.00 |
| Mar 31, 2026 | -53,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Sep 30, 2025 | -386,000.00 |
| Sep 30, 2025 | -386,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Mar 31, 2025 | -211,000.00 |
| Mar 31, 2025 | -211,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -31,000.00 |
| Jun 30, 2024 | -31,000.00 |
| Mar 31, 2024 | -330,000.00 |
| Mar 31, 2024 | -330,000.00 |
| Dec 31, 2023 | -46,000.00 |
| Dec 31, 2023 | -46,000.00 |